Table 2 Patient characteristics and histology
No. | Age | Sex | Tumor size (mm) | Histology | Pre-op pulmonary functional test | Clinical stage | Neoadjuvant treatment | ||
|---|---|---|---|---|---|---|---|---|---|
FEV1% | FEV1/FVC% | DLCo% | |||||||
1 | 64 | Male | 35 | Squamous cell | 88.4 | 80.3 | 63.7 | T2N0M0, IB | No |
2 | 60 | Female | 20 | Carcinoid | 93.1 | 83.7 | 67.2 | T2N0M0, IB | No |
3 | 59 | Female | 28 | Adenocarcinoma | 85.4 | 77.8 | 59.3 | T2N0M0, IB | No |
4 | 67 | Male | 35 | Squamous cell | 93.9 | 82.6 | 65.1 | T2N1M0, IIB | No |
5 | 73 | Male | 42 | Squamous cell | 62.5 | 60.4 | 50.9 | T2N1M0, IIB | No |
6 | 49 | Female | 30 | Adenocarcinoma | 76.9 | 69.3 | 61.4 | T2N0M0, IB | No |